Arquer Diagnostics Ltd Company Profile

06:58 EDT 21st September 2019 | BioPortfolio

Arquer Diagnostics (Arquer) is a private, UK-based diagnostics company focused on the development and commercialisation of a non-invasive immunoassay diagnostic test for bladder and prostate cancer. Arquer’s diagnostic test, the MCM5-ELISA, detects the presence of minichromosome maintenance (MCM) protein, a marker for the presence of dividing cancer cells, in urine. MCM proteins are excellent biomarkers, being directly involved in cell replication, and are shed into urine by both prostate and bladder tumours. Arquer’s test is based on intellectual property licensed exclusively from Cancer Research Technology (CRT), the development and commercialisation arm of Cancer Research UK. The non-invasive, urine-based ELISA and Point-of Care tests being developed by Arquer meet the increased demand for cost-effective healthcare technologies that not only enhance patient care but help to reduce overall healthcare costs by improving patient outcomes. The MCM5-ELISA is expected to significantly reduce the number of patients undergoing invasive and costly techniques such as cystoscopy and biopsy, because it offers highly accurate diagnostic results from small amounts of body fluid.


North East Business and Innovation Centre, Wearfield
Enterprise Park East
United Kingdom


Phone: +44 (0) 191 516 6765

News Articles [438 Associated News Articles listed on BioPortfolio]

Lumos Diagnostics merges with RPS Diagnostics

Lumos Diagnostics is a California-based full-service point-of-care (POC) diagnostic development company, while RPS Diagnostics is a Florida-based commercial diagnostic developer, manufacturer, and mar...

Molecular Diagnostics Picks Up the Pace

Kalorama Information estimates that the market for molecular diagnostics is worth $8.7 billion and will reach $12.9 billion by 2024, outpacing growth in traditional in vitro diagnostics. The post Mole...

Co-Diagnostics opens new manufacturing joint venture facility in India

The manufacturing facility has been built for CoSara Diagnostics (CoSara), which marks one of the first facilities for manufacturing molecular diagnostics in India. Co-Diagnostics said that the facili...

The World Molecular Diagnostics Market, 2019 Edition – Focus on CT/NG, HPV, Hepatitis, HIV, HAIs, Respiratory Diseases, and Tuberculosis –

DUBLIN–(BUSINESS WIRE)–The “The World Molecular Diagnostics Market, 8th Edition” report has been added to’s offering. Molecular diagnostics is a fa...

VC firm brings in $12.5M for Specific Diagnostics

Venture capital firm Telegraph Hill Partners has provided $12.5 million for in vitro diagnostics firm Specific Diagnostics.  -More- 

Burning Rock of Guangzhou Raises $126 Million for NGS Diagnostics

Burning Rock Biotech, a Guangzhou diagnostics company, closed a $126 million Series C financing led by GIC (the Sovereign Wealth Fund of Singapore). Burning Rock specializes in oncology diagnostics fo...

Genecast (Beijing) and US-based Interpace Form Diagnostics Partnership

Genecast (Beijing) Biotech, a cancer diagnostics company, partnered with Interpace Diagnostics of New Jersey to offer translational studies and clinical trial diagnostics to biopharma companies. Accor...

Exact Sciences and Genomic Health Merge to Form Leading Cancer Diagnostics Company

The combined companies will have revenue drivers of two commercially available diagnostics tools, Cologuard and Oncotype DX.

PubMed Articles [225 Associated PubMed Articles listed on BioPortfolio]

Introduction to Special Issue on "Electromagnetic Technologies for Medical Diagnostics: Fundamental Issues, Clinical Applications and Perspectives".

The application of microwave technologies in medical imaging and diagnostics is an emerging topic within the electromagnetic (EM) engineering community [...].

Possibilities of modern x-ray examination methods for diagnostics of hidden dental caries of approximal localization.

Introduction: In case of hidden carious cavities development on the approximal teeth surfaces, the clinical diagnostics of this process is difficult. Then, the diagnostics of carious lesion is not pos...

Optimization of the preanalytical phase of laboratory diagnostics in intensive care and disaster medicine.

The use of point-of-care diagnostics can prevent a number of complications and leading to improved health outcomes for patients in critical condition. Research have shown that elongation of the preana...

Nucleic acid diagnostics on the total integrated lab-on-a-disc for point-of-care testing.

Since the emergence of the lab-on-a-chip technology in 1979, a variety of microfluidic devices have been developed and utilized for chemical and biological applications. Among the microfluidic devices...

The labyrinth of product development and regulatory approvals in liquid biopsy diagnostics.

The evolution of chemistries and instrument platforms for Next Generation Sequencing (NGS) has led to sequencing of genomic variants in both tumor biopsies as well as in Circulating Tumor Cells (CTC) ...

Clinical Trials [281 Associated Clinical Trials listed on BioPortfolio]

Differential Diagnostics of Etiology of Acute Infections

Method for diagnostics of the origin of infections (bacterial vs viral) based on the identification of activation markers of blood neutrophils and monocytes will be developed.

Diagnostics and Pharmacotherapy for Severe Forms of TB (DMID 15-0100)

Major Research Aim: To study novel molecular diagnostics and the pharmacokinetic variability among a spectrum of TB disease states, including severe forms of TB like disseminated TB, TB me...

Bedside vs. Standard Microbiological Blood Culture Diagnostics - BEMIDIA Study

With a completely bedside blood culture diagnostics system (BACTEC blood culture system in combination with the Accelerate ID/AST System) it is possible to optimize the initial antimicrobi...

MP Diagnostics HTLV Blot 2.4 Post-Market Clinical Study

The purpose of this study is to assess the performance of the HTLV Blot 2.4 from patients with the following conditions: infected with HTLV and neurological conditions with symptoms simila...

Non-Invasive Diagnostics of Small Renal Masses

NiSAR is a Ph.D. study and consists of three substudies. Renal cancer is one of the most deadly urologic malignancies and accounts for 900 new cases and 300 deaths per year. An increase in...

Companies [972 Associated Companies listed on BioPortfolio]

Sekisui Diagnostics

A Sekisui Chemical company since 2011, Sekisui Diagnostics is a leading supplier of high quality products to diagnostic manufacturers, clinical laboratories and physician offices ...

Innotrac Diagnostics Oy

Founded 1995Located in Turku, FinlandInnotrac Diagnostics provides health care professionals with a comprehensive immunoassay platform and test portfolio for rapid and high quality results in cardiac ...

Cleveland Diagnostics, Inc.

Cleveland Diagnostics, Inc., is a clinical-stage biotechnology company developing technology to improve cancer diagnostics. Its Solvent Interaction Analysis (SIA) technology inves...

Critical Diagnostics Critical Diagnostics

Critical Diagnostics ( develops novel biomarkers to help physicians optimize patient care in cardiovascular diseases, while containing healthcare costs...

ERBA Diagnostics Inc.

ERBA Diagnostics, Inc. (, headquartered in Miami Lakes, Florida, is a fully integrated in vitro diagnostics company that develops, manufactures and distrib...

More Information about "Arquer Diagnostics Ltd" on BioPortfolio

We have published hundreds of Arquer Diagnostics Ltd news stories on BioPortfolio along with dozens of Arquer Diagnostics Ltd Clinical Trials and PubMed Articles about Arquer Diagnostics Ltd for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Arquer Diagnostics Ltd Companies in our database. You can also find out about relevant Arquer Diagnostics Ltd Drugs and Medications on this site too.

Quick Search

Relevant Topics

A diagnostic test is any kind of medical test performed to aid in the diagnosis or detection of disease. For example: to diagnose diseases to measure the progress or recovery from disease to confirm that a person is free from disease Clin...

Bladder Cancer
Non-invasive bladder cancer is a cancer that is only in the inner lining of the bladder. Invasive bladder cancer is cancer that has spread into the deeper walls of the bladder. When the cancer has spread outside the bladder to other parts of the body, th...

Corporate Database Quicklinks

Searches Linking to this Company Record